Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tailor

Showing results (851-860 of 913) with videos related to

Pageof 92
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|June 7, 2025
Guidelines on Management of Multiple Myeloma in the Relapsed/Refractory Setting: The Saudi Myeloma Working Group GuidelineAyman Alhejazi, Ghazi S Alotaibi, Abdullah S Al Saleh, et al.
Medical Image Analysis|April 10, 2025
Virtual lung screening trial (VLST): An in silico study inspired by the national lung screening trial for lung cancer detectionFakrul Islam Tushar, Liesbeth Vancoillie, Cindy McCabe, et al.
British Journal of Cancer|November 3, 2020
Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancerDhanir Tailor, Catherine C Going, Angel Resendez, et al.
Arxiv|May 3, 2024
Virtual Lung Screening Trial (VLST): An <i>In Silico</i> Replica of the National Lung Screening Trial for Lung Cancer DetectionFakrul Islam Tushar, Liesbeth Vancoillie, Cindy McCabe, et al.
Cancer Research|June 28, 2022
Reengineering Ponatinib to Minimize Cardiovascular ToxicityAnna P Hnatiuk, Arne A N Bruyneel, Dhanir Tailor, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2025
Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma: The Saudi Myeloma Working Group GuidelinesGhazi S Alotaibi, Abdullah S Al Saleh, Ayman Alhejazi, et al.
Oncotarget|August 7, 2019
Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinomaOmkara Lakshmi Veeranki, Zhimin Tong, Rashmi Dokey, et al.
Ophthalmology Science|April 25, 2024
A Comparative Study of Responses to Retina Questions from Either Experts, Expert-Edited Large Language Models, or Expert-Edited Large Language Models AlonePrashant D Tailor, Lauren A Dalvin, John J Chen, et al.
Gut|June 22, 2014
CCK2R identifies and regulates gastric antral stem cell states and carcinogenesisYoku Hayakawa, Guangchun Jin, Hongshan Wang, et al.
Cancer Research|May 3, 2019
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic CancerTara N Fujimoto, Lauren E Colbert, Yanqing Huang, et al.
Pageof 92

Showing results (851-860 of 913) with videos related to

Sort By:
Pageof 92
Clinical Lymphoma, Myeloma & Leukemia|June 7, 2025
Guidelines on Management of Multiple Myeloma in the Relapsed/Refractory Setting: The Saudi Myeloma Working Group GuidelineAyman Alhejazi, Ghazi S Alotaibi, Abdullah S Al Saleh, et al.
Medical Image Analysis|April 10, 2025
Virtual lung screening trial (VLST): An in silico study inspired by the national lung screening trial for lung cancer detectionFakrul Islam Tushar, Liesbeth Vancoillie, Cindy McCabe, et al.
British Journal of Cancer|November 3, 2020
Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancerDhanir Tailor, Catherine C Going, Angel Resendez, et al.
Arxiv|May 3, 2024
Virtual Lung Screening Trial (VLST): An <i>In Silico</i> Replica of the National Lung Screening Trial for Lung Cancer DetectionFakrul Islam Tushar, Liesbeth Vancoillie, Cindy McCabe, et al.
Cancer Research|June 28, 2022
Reengineering Ponatinib to Minimize Cardiovascular ToxicityAnna P Hnatiuk, Arne A N Bruyneel, Dhanir Tailor, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2025
Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma: The Saudi Myeloma Working Group GuidelinesGhazi S Alotaibi, Abdullah S Al Saleh, Ayman Alhejazi, et al.
Oncotarget|August 7, 2019
Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinomaOmkara Lakshmi Veeranki, Zhimin Tong, Rashmi Dokey, et al.
Ophthalmology Science|April 25, 2024
A Comparative Study of Responses to Retina Questions from Either Experts, Expert-Edited Large Language Models, or Expert-Edited Large Language Models AlonePrashant D Tailor, Lauren A Dalvin, John J Chen, et al.
Gut|June 22, 2014
CCK2R identifies and regulates gastric antral stem cell states and carcinogenesisYoku Hayakawa, Guangchun Jin, Hongshan Wang, et al.
Cancer Research|May 3, 2019
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic CancerTara N Fujimoto, Lauren E Colbert, Yanqing Huang, et al.
Pageof 92